SEROLOGIC RESPONSE TO ORAL POLIO VACCINE AND ENHANCED-POTENCY INACTIVATED POLIO VACCINES
The DOI matches its Crossref record.
Abstract
In a randomized, controlled trial carried out from November 1980 to July 1983 involving 1,114 infants in Baltimore City and in Baltimore and Prince George's counties, Maryland, the serologic response to three doses of two enhanced-potency inactivated polio vaccines was compared with the response to three doses of oral polio vaccine. The mean ages at vaccination were 2.2, 4.7, and 19.9 months, respectively, for the three doses. Seroconversion after the first dose varied from 35% to 84%, and it was higher after oral polio vaccine than after either of the enhanced-potency inactivated polio vaccines for polioviruses types 2 and 3. Approximately two and one-half and 16 months after the second dose, almost all inactivated polio vaccine recipients had antibodies against all three virus types (98-100%). Fewer oral polio vaccine recipients had detectable antibodies to type 1 (89-92%) and to type 3 (96%). After three doses of vaccine, all children had antibodies against types 2 and 3. Approximately 1% of the inactivated polio vaccine recipients and 3% of the oral polio vaccine recipients lacked antibody to type 1. One or two doses of oral polio vaccine stimulated higher reciprocal geometric mean antibody titers against type 2 poliovirus than did the inactivated polio vaccine. For the other two types, the results were mixed. The third dose of inactivated polio vaccine produced significant increases in the reciprocal geometric mean titers against each of the three poliovirus types and resulted in significantly higher reciprocal geometric mean titers after three doses of vaccine for recipients of inactivated polio vaccine than for recipients of oral polio vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review.
Patriarca, P. A., Wright, P. F., & John, T. J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.5.926 · Cited by 453
Paralytic poliomyelitis: Seasoned strategies, disappearing disease
Hull, H. F., Ward, N. A., Hull, B. P., Milstien, J. B., Hull, H. F., & de Quadros, C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92472-4 · Cited by 235
Poliovirus vaccination options for achieving eradication and securing the endgame
Estívariz, C. F., Pallansch, M. A., Anand, A., Wassilak, S. G., Sutter, R. W., Wenger, J. D., & Orenstein, W. A. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.05.007 · Cited by 66
Sutter (2000) · doi:10.1016/s0031-3955(05)70208-x · Cited by 28
Inactivated and live, attenuated poliovirus vaccines: mucosal immunity.
Sutter, R. W., & Patriarca, P. A. (1993) · Measles and Poliomyelitis · doi:10.1007/978-3-7091-9278-8_23 · Cited by 23
Metadata
- Authors
- McBEAN, A. M., THOMS, M. L., ALBRECHT, P., CUTHIE, J. C., BERNIER, R., & THE FIELD STAFF AND COORDINATING COMMITTEE
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1988-09-01
- Volume
- 128
- Issue
- 3
- Pages
- 615-628
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2109820685
- Cited by
- 129
- References
- 0
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SEROLOGIC RESPONSE TO ORAL POLIO VACCINE AND ENHANCED-POTENCY INACTIVATED POLIO VACCINES. https://app.cochat.ai/papers/10.1093/oxfordjournals.aje.a115009
- The paper
- McBEAN, A. M., THOMS, M. L., ALBRECHT, P., CUTHIE, J. C., BERNIER, R., & THE FIELD STAFF AND COORDINATING COMMITTEE. (1988). SEROLOGIC RESPONSE TO ORAL POLIO VACCINE AND ENHANCED-POTENCY INACTIVATED POLIO VACCINES. American Journal of Epidemiology. https://doi.org/10.1093/oxfordjournals.aje.a115009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.